Mubritinib Uses, Dosage, Side Effects and more
Mubritinib has been used in trials studying the treatment of Lung Neoplasm, Renal Neoplasm, Breast Neoplasm, Ovarian Neoplasm, and Pancreatic Neoplasm.
| Trade Name | Mubritinib |
| Generic | Mubritinib |
| Mubritinib Other Names | Mubritinib |
| Type | |
| Formula | C25H23F3N4O2 |
| Weight | Average: 468.48 Monoisotopic: 468.177310486 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
